Resources

This injectable drug class focuses on the incretin system and leads to increased insulin secretion, decreased glucagon secretion, and slowed gastric emptying. One of its advantages is that its use can lead to weight loss: 1. GLP-1 receptor agonists 2. SGLT-2 Inhibitors 3. DPP-IV 4. Sulfonylureas Did you get the right answer? Follow the link to find out!

Do you feel that with our new president, changes to the Affordable Care Act will be: 1. Negative 2. Positive 3. Unsure Follow the link to share your opinion and see what your colleagues think!

Laurie Klipfel, RN, MSN, BC-ANP, CDE was recently asked if she could offer any pearls of wisdom for another Disaster Averted regarding a patient with type 1 diabetes who couldn't afford his analog insulin. After reading her advice, keep reading to learn how you can take action to help make insulin more affordable.

Dr. Jeffrey Mechanick talks with Diabetes in Control Publisher Steve Freed at the 2016 AACE Meeting. In part 5 of this Exclusive Interview, Dr. Mechanick explains how he helps patients determine ways to improve their lifestyle.

In this week's Homerun Slides, blood-based glucose sensors vs. subcutaneous CGM sensors.

Secretion of incretin hormones: The mucosa of the intestinal tract harbors a large number of endocrine cells that give rise to various peptide hormones. These include cholecystokinin, motilin, secretin, gastrin, gastric inhibitory polypeptide (GIP, also referred to as glucose-dependent insulinotropic polypeptide), glucagon-like peptide 1 (GLP-1), glucagon-like peptide 2, and peptide YY.

In 2016, the TYK questions that received the most interest from our readers were those with a personal touch: questions that gave case-study style descriptions of individual patients and their needs. The 5 most popular questions of the year are featured in this issue. Can you guess which of these 2016 TYK questions was the most popular of all? A. Question #814, January 2: Unnamed patient B. Question #817, January 23: Mrs. O'Doole C. Question #823, March 5: Mrs. Hunter D. Question #833, May 14: Mrs. Wilson E. Question #835, May 26: Mr. Fontello

You can view the top 5 questions of 2016 in one page here.

In a year that saw much discussion about new drugs, new devices, and how politics might affect medical care, the surveys you were most interested in were those that touched on the core aspects of care for patients with diabetes. See the five polls that engaged you most.

Why do you respond to DIC survey questions? 1. Because the question is interesting 2. Want to share my opinion 3. Want to see what my colleagues think 4. All of the above 5. I usually don't respond